Market Overview

Wedbush Initiates Novavax At Outperform

Share:

Analysts at Wedbush initiated coverage on shares of Novavax (NASDAQ: NVAX) with a Outperform rating.

The target price for Novavax is set to $10.

Novavax shares have jumped 43.59% over the past 52 weeks, while the S&P 500 index has gained 17.63% in the same period.

Novavax's shares rose 0.67% to $4.51 in after-hours trading.

Latest Ratings for NVAX

DateFirmActionFromTo
Dec 2020JefferiesInitiates Coverage OnBuy
Nov 2020HC Wainwright & Co.MaintainsBuy
Aug 2020HC Wainwright & Co.MaintainsBuy

View More Analyst Ratings for NVAX
View the Latest Analyst Ratings

 

Related Articles (NVAX)

View Comments and Join the Discussion!

Posted-In: WedbushInitiation Analyst Ratings

Latest Ratings

StockFirmActionPT
SLABMorgan StanleyInitiates Coverage On143.0
QTSRaymond JamesUpgrades74.0
EQIXRaymond JamesUpgrades835.0
MKTXRosenblattUpgrades588.0
IPGPNeedhamUpgrades280.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com